SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-03-028031
Filing Date
2003-12-08
Accepted
2003-12-08 17:16:33
Documents
5
Period of Report
2003-12-04
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a03-6030_18k.htm 8-K 23629
3 EX-10.48 a03-6030_1ex10d48.htm EX-10.48 173112
4 EX-10.49 a03-6030_1ex10d49.htm EX-10.49 77533
5 EX-10.50 a03-6030_1ex10d50.htm EX-10.50 90238
6 EX-99.1 a03-6030_1ex99d1.htm EX-99.1 10391
  Complete submission text file 0001104659-03-028031.txt   377040
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 031043083
SIC: 2834 Pharmaceutical Preparations